BUDESONE

This brand name is authorized in Nigeria.

Active ingredients

The drug BUDESONE contains one active pharmaceutical ingredient (API):

1	Budesonide UNII Q3OKS62Q6X - BUDESONIDE
	Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.
	Read more about Budesonide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1503	Aerosol, Metered-Dose	Budesone-100 Inhaler AER_SPRAY 100 mcg/Inhalation		21/12/2020
C4-1504	Aerosol, Metered-Dose	Budesone-200 Inhaler AER_SPRAY 200 mcg/Inhalation		21/12/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BA02	Budesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1503, C4-1504